The National Drug Abuse Treatment Clinical Trials Network (U10)

archived

Purpose. This Funding Opportunity Announcement (FOA) from the National Institute on Drug Abuse (NIDA) announces a competition for new cooperative agreement applications and cooperative agreement renewal applications from established clinical investigators to participate in the National Drug Abuse Treatment Clinical Trials Network (CTN). As a nation-wide partnership for translational research among addiction treatment providers, researchers, and NIDA staff, the CTNs mission is to test and validate effective and efficient treatments that can be adopted by addiction treatment providers throughout the Nation, using science as the vehicle. The CTN provides an enterprise in which community-based addiction service providers, other health practitioners working with patients that have addiction problems, addiction treatment researchers, and NIDA cooperatively develop, validate, refine, and deliver new treatment options for patients in community-level clinical practice. Mechanism of Support. This FOA will utilize the National Institutes of Health (NIH) cooperative agreement (U10) award mechanism. Funds Available and Anticipated Number of Awards. In response to this FOA, the National Institute on Drug Abuse (NIDA) anticipates that approximately $13.5 million in total costs in FY2010 will be awarded to fund up to 12 applications for this announcement.

High